Pradžia › Krono liga › Mičiganas
Krono liga klinikiniai tyrimai Mičiganas
20 tyrimai dėl Krono liga ieško dalyvių vietose Mičiganas.
Miestai Mičiganas
Oficialus tyrimo tekstas (anglų kalba)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- St. Joseph Mercy Hospital - Huron Gastroenterology Associates ( Site 0287), Ypsilanti
Renkami dalyviai3 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-10-02 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Michigan ( Site 5060), Ann Arbor
- Clinical Research Institute of Michigan, LLC ( Site 5002), Clinton Township
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- West Michigan Clinical Research Center /ID# 280480, Wyoming
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
- Huron Gastro, Ypsilanti
Renkami dalyviai4 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Henry Ford Medical Center - Columbus /ID# 266503, Novi
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Michigan Center of Medical Research, Farmington Hills
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07499232An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Henry Ford Medical Center - Columbus-Site Number: 8400118, Novi
- Gastroenterology Associates of Western Michigan-Site Number: 8400060, Wyoming
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07184931A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Huron Gastroenterology Associates, P.C., Ypsilanti
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Michigan Center of Medical Research, Farmington Hills
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT07577843A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital of Michigan, Detroit
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06100289Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
- University of Micigan, Ann Arbor
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-23 · NCT07456566A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Hospital of Michigan, Detroit
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-06-22 · NCT06405087Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- University of Michigan, Ann Arbor
Renkami dalyviai4 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-05-27 · NCT05781152Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Henry Ford Columbus Center, Detroit
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-04-27 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400008, Wyoming
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-03-27 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Ypsilanti
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-03-12 · NCT07113522A Pilot Study Examining Low Sulfur Diet as Treatment for Persistent Symptoms in Quiescent Crohn's Disease
- University of Michigan, Ann Arbor
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-15 · NCT05849012Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Michigan, Ann Arbor
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2025-12-10 · NCT06721962Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.